5-36260854-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_145000.5(RANBP3L):​c.595A>G​(p.Asn199Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000378 in 1,322,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000038 ( 0 hom. )

Consequence

RANBP3L
NM_145000.5 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.09
Variant links:
Genes affected
RANBP3L (HGNC:26353): (RAN binding protein 3 like) Enables SMAD binding activity. Predicted to be involved in several processes, including mesenchymal cell differentiation involved in bone development; negative regulation of osteoblast differentiation; and positive regulation of myoblast differentiation. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.093317956).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RANBP3LNM_145000.5 linkc.595A>G p.Asn199Asp missense_variant Exon 8 of 14 ENST00000296604.8 NP_659437.3 Q86VV4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RANBP3LENST00000296604.8 linkc.595A>G p.Asn199Asp missense_variant Exon 8 of 14 1 NM_145000.5 ENSP00000296604.3 Q86VV4-1
RANBP3LENST00000502994.5 linkc.670A>G p.Asn224Asp missense_variant Exon 9 of 15 2 ENSP00000421853.1 Q86VV4-3
RANBP3LENST00000515759.5 linkc.595A>G p.Asn199Asp missense_variant Exon 8 of 10 2 ENSP00000421149.1 Q86VV4-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000454
AC:
1
AN:
220284
AF XY:
0.00000841
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000584
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000378
AC:
5
AN:
1322944
Hom.:
0
Cov.:
20
AF XY:
0.00000603
AC XY:
4
AN XY:
663308
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30488
American (AMR)
AF:
0.00
AC:
0
AN:
41858
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24740
East Asian (EAS)
AF:
0.000129
AC:
5
AN:
38768
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80288
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52250
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5512
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
993622
Other (OTH)
AF:
0.00
AC:
0
AN:
55418
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 28, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.670A>G (p.N224D) alteration is located in exon 9 (coding exon 9) of the RANBP3L gene. This alteration results from a A to G substitution at nucleotide position 670, causing the asparagine (N) at amino acid position 224 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0026
T;.;.
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.067
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.60
T;T;T
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.093
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L;.;L
PhyloP100
1.1
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.86
N;N;N
REVEL
Benign
0.057
Sift
Benign
0.23
T;T;T
Sift4G
Benign
0.45
T;T;T
Polyphen
0.0010
B;.;.
Vest4
0.24
MutPred
0.24
Gain of disorder (P = 0.15);.;Gain of disorder (P = 0.15);
MVP
0.048
MPC
0.11
ClinPred
0.064
T
GERP RS
4.1
Varity_R
0.11
gMVP
0.11
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1409058579; hg19: chr5-36260956; API